Some brands of long acting Metformin are being recalled since they contain higher than acceptable levels of NDMA (see list below).
The U.S. Food and Drug Administration has recommended recalls of certain metformin products that may contain the impurity N-nitrosodimethylamine (NDMA) above the acceptable intake limit.
Patients taking recalled metformin should continue taking it until a doctor or pharmacist gives them a replacement or a different treatment option. It could be dangerous for patients with type 2 diabetes to stop taking their metformin without first talking to their health care professional.
Remind patients not to stop medication until they check with their provider.
Find more info on the FDA Website here
For a complete listing of diabetes medications and insulin, download our DiabetesEd Medication PocketCards
April 14, 2021 – April 16, 2021
August 5 11:30 am – 1:00 pm
August 6 11:30 am – 12:45 pm
August 26 11:30 am – 1:00 pm
September 2 11:30 am – 1:00 pm
September 20 11:30 am – 1:00 pm